WP1220
MB-201
Phase 1 small_molecule completed
Quick answer
WP1220 for Cutaneous T-Cell Lymphoma/Mycosis Fungoides is a Phase 1 program (small_molecule) at Moleculin Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Moleculin Biotech
- Indication
- Cutaneous T-Cell Lymphoma/Mycosis Fungoides
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed